Fulcrum Therapeutics Inc. (FULC) Misses Q1 EPS by 2c
Tweet
Share
E-mail
Get Alerts FULC Hot Sheet
Join SI Premium – FREE
Fulcrum Therapeutics Inc. (NASDAQ: FULC) reported Q1 EPS of ($0.28), $0.02 worse than the analyst estimate of ($0.26).
For earnings history and earnings-related data on Fulcrum Therapeutics Inc. (FULC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Putin Said To Plan Ukraine Escalation, Seeing Talks Fruitless - Bloomberg
- J. M. Smucker (SJM) Tops Q1 EPS by 103c
- Freedom Broker Downgrades CF Industries (CF) to Hold, 'Strong Half, Softer Base Ahead'
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
